pilocarpine hydrochloride: prescribing and clinical use
Focused clinical detail for use alongside current product information, local policy and patient-specific assessment.
pilocarpine hydrochloride: clinical details
Prescribing considerations
- Confirm formulation and licensed indication; oral and ophthalmic products are not interchangeable.
- Assess respiratory, cardiovascular, renal, biliary, gastrointestinal, psychiatric and ocular history before oral treatment.
- Consider dehydration risk where sweating is likely and fluid intake is limited.
- For ocular use, assess retinal risk and account for possible systemic absorption.
- Oral paediatric safety and efficacy are not established; paediatric ocular use requires specialist direction.
Contraindications and cautions
- Hypersensitivity to pilocarpine or formulation excipients.
- Oral product: clinically significant uncontrolled cardiorenal disease, uncontrolled asthma or another chronic disorder endangered by cholinergic stimulation.
- Oral product: conditions where miosis is undesirable, including acute iritis.
- Selected eye drops: acute iritis, anterior uveitis, some secondary glaucomas and use with soft contact lenses.
Monitoring
- For chronic ocular treatment, monitor intraocular pressure and visual fields; perform fundus assessment before starting in patients at retinal risk.
- With oral treatment, review symptom response, sweating and hydration, respiratory tolerability, cardiovascular effects and visual adverse effects.
- Review promptly if bronchospasm, conduction disturbance, marked hypotension or neuropsychiatric effects occur.
Clinical pharmacology
A direct muscarinic receptor agonist that stimulates exocrine secretion and smooth muscle. Ocular ciliary-muscle and iris-sphincter contraction produces miosis and facilitates trabecular aqueous outflow. Oral pilocarpine is principally metabolised through CYP2A6 and serum esterases.
Formulation and product differences
- The oral film-coated tablet produces systemic glandular and smooth-muscle effects.
- Selected multidose eye drops act locally but can be absorbed systemically.
- Selected eye drops contain benzalkonium chloride and are unsuitable with soft contact lenses.
pilocarpine hydrochloride preparations and strengths
Eye drops
Route: Ophthalmic
Strengths: 1.0% w/v, 2.0% w/v, 4.0% w/v
Tablet
Route: Oral
Strengths: 5 mg
pilocarpine hydrochloride interactions
Interaction relevance depends on whether pilocarpine is taken orally or used in the eye and how much is absorbed systemically.
Beta-blockers
Oral pilocarpine may increase the risk of cardiac conduction disturbances.
Other parasympathomimetics or anticholinesterases
Cholinergic effects, such as sweating, salivation, gastrointestinal effects or slow heart rate, may be increased.
Anticholinergics, including atropine and inhaled ipratropium
Pilocarpine and these medicines may oppose each other’s effects.
Sources
These sources were used to prepare and review this medicine page.
Prepared and reviewed by the iatroX editorial team.